During the past decade, Island Dermatology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Island Dermatology" are "Atopic Dermatitis" (1 trials), "Nodular Basal Cell Carcinoma" (1 trials) and "Superficial Basal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Island Dermatology" in a lesser frequency.

Most popular intervention types in "Island Dermatology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "AIV001" (1 trials), "Placebo" (1 trials) and "Tralokinumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Island Dermatology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Island Dermatology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Island Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Island Dermatology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".